Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.

Abstract:

:p27 restrains normal cell growth, but PI3K-dependent C-terminal phosphorylation of p27 at threonine 157 (T157) and T198 promotes cancer cell invasion. Here, we describe an oncogenic feedforward loop in which p27pT157pT198 binds Janus kinase 2 (JAK2) promoting STAT3 (signal transducer and activator of transcription 3) recruitment and activation. STAT3 induces TWIST1 to drive a p27-dependent epithelial-mesenchymal transition (EMT) and further activates AKT contributing to acquisition and maintenance of metastatic potential. p27 knockdown in highly metastatic PI3K-activated cells reduces STAT3 binding to the TWIST1 promoter, TWIST1 promoter activity and TWIST1 expression, reverts EMT and impairs metastasis, whereas activated STAT3 rescues p27 knockdown. Cell cycle-defective phosphomimetic p27T157DT198D (p27CK-DD) activates STAT3 to induce a TWIST1-dependent EMT in human mammary epithelial cells and increases breast and bladder cancer invasion and metastasis. Data support a mechanism in which PI3K-deregulated p27 binds JAK2, to drive STAT3 activation and EMT through STAT3-mediated TWIST1 induction. Furthermore, STAT3, once activated, feeds forward to further activate AKT.

journal_name

Oncogene

journal_title

Oncogene

authors

Zhao D,Besser AH,Wander SA,Sun J,Zhou W,Wang B,Ince T,Durante MA,Guo W,Mills G,Theodorescu D,Slingerland J

doi

10.1038/onc.2014.473

subject

Has Abstract

pub_date

2015-10-01 00:00:00

pages

5447-59

issue

43

eissn

0950-9232

issn

1476-5594

pii

onc2014473

journal_volume

34

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Molecular cloning of a recombinant retrovirus carrying a mutated envAKR-mycMH2 fusion gene immortalizing cells of the monocytic-macrophage lineage.

    abstract::The VN-11 recombinant retroviruses, originally generated by co-transfection of the avian MH2 and AKRv viral genomes, were molecularly cloned from an infected mouse cell line named N11. The analysis of the proviral genome sequence from one of these recombinants showed a possible envAKR-mycMH2 fusion. Point mutations we...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sassano M,Granucci F,Seveso M,Marconi G,Foti M,Ricciardi-Castagnoli P

    更新日期:1994-05-01 00:00:00

  • The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase.

    abstract::Leukocyte tyrosine kinase (LTK) is a receptor tyrosine kinase which belongs to the insulin receptor superfamily and is mainly expressed in pre-B lymphocytes and neuronal tissues. Recently, we demonstrated that LTK utilizes Shc and IRS-1 as two major substrates and while both equally activate the Ras pathway, only IRS-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201153

    authors: Ueno H,Honda H,Nakamoto T,Yamagata T,Sasaki K,Miyagawa K,Mitani K,Yazaki Y,Hirai H

    更新日期:1997-06-26 00:00:00

  • MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma.

    abstract::One-carbon metabolism plays a central role in a broad array of metabolic processes required for the survival and growth of tumor cells. However, the molecular basis of how one-carbon metabolism may influence RNA methylation and tumorigenesis remains largely unknown. Here we show MTHFD2, a mitochondrial enzyme involved...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0869-4

    authors: Green NH,Galvan DL,Badal SS,Chang BH,LeBleu VS,Long J,Jonasch E,Danesh FR

    更新日期:2019-08-01 00:00:00

  • Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice.

    abstract::Functional alterations or loss of tumor-suppressor genes are an important feature of neoplastic progression in humans. The employment of suitable animal model systems would greatly facilitate the detection and manipulation of such genes. We describe here an experimental approach to this problem based on the analysis o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Burns PA,Kemp CJ,Gannon JV,Lane DP,Bremner R,Balmain A

    更新日期:1991-12-01 00:00:00

  • A role for Ubc9 in tumorigenesis.

    abstract::The post-translational modifications ubiquitination and sumoylation have been implicated in regulating many critical cellular pathways. Like ubiquitination, sumoylation is a multistep process involving maturation, activation, conjugation and deconjugation. Ubc9 is a sole E2-conjugating enzyme essential for sumoylation...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208210

    authors: Mo YY,Yu Y,Theodosiou E,Ee PL,Beck WT

    更新日期:2005-04-14 00:00:00

  • HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells.

    abstract::SH3 and SAM domains are protein interaction motifs that are predominantly seen in signaling molecules, adaptors, and scaffold proteins. We have identified a novel family of putative adaptor genes that includes HACS1. HACS1 encodes a 441 amino acid protein that is differentially expressed in hematopoietic cells and has...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204698

    authors: Claudio JO,Zhu YX,Benn SJ,Shukla AH,McGlade CJ,Falcioni N,Stewart AK

    更新日期:2001-08-30 00:00:00

  • The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.

    abstract::NIH sponsored a meeting of medical and veterinary pathologists with mammary gland expertise in Annapolis in March 1999. Rapid development of mouse mammary models has accentuated the need for definitions of the mammary lesions in genetically engineered mice (GEM) and to assess their usefulness as models of human breast...

    journal_title:Oncogene

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1038/sj.onc.1203277

    authors: Cardiff RD,Anver MR,Gusterson BA,Hennighausen L,Jensen RA,Merino MJ,Rehm S,Russo J,Tavassoli FA,Wakefield LM,Ward JM,Green JE

    更新日期:2000-02-21 00:00:00

  • DNA: leukemia's secret weapon of bone mass destruction.

    abstract::Interaction of tumour cells with their microenvironment impacts on all aspects of cancer, ranging from development through to treatment response. In this issue, Dvorak and colleagues(1) reveal a novel tumour/microenvironment relationship that may drive leukemia pathogenesis. Specifically, they find that leukemic cells...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2012.639

    authors: Tait S

    更新日期:2013-10-31 00:00:00

  • New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.

    abstract::Telomeres are stabilized, and telomeric DNA is replenished, by the action of the ribonucleoprotein reverse transcriptase telomerase. Telomere capping functions include the ability of telomeres to protect chromosome ends from cellular DNA-damage responses such as cell cycle arrest or apoptosis. This property of telomer...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205082

    authors: Chan SW,Blackburn EH

    更新日期:2002-01-21 00:00:00

  • Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.

    abstract::Cancer therapy drugs, such as diamminedichloroplatinum (cisplatin), mitomycin C, etoposide and a number of other compounds, as well as energy-rich radiation, are known to act on cellular DNA. These agents are shown to induce nuclear accumulation of the so-called tumor-suppressor protein p53 in fibroblastoid cells, as ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Fritsche M,Haessler C,Brandner G

    更新日期:1993-02-01 00:00:00

  • Association of v-myc protein with chromatin.

    abstract::The subnuclear distribution of proteins encoded by v-myb and v-myc was analysed in a cell-line of AMV-transformed chicken myeloblasts superinfected by the myc-containing retrovirus MC29. p45v-myb and p110gag-myc, co-expressed in these cells, were released in similar fashion when nuclei were treated with salt or DNAase...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Klempnauer KH

    更新日期:1989-01-01 00:00:00

  • Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

    abstract::The RAS-RAF-MEK-ERK signaling cascade is among the most frequently mutated pathways in human cancer. Approximately 50% of melanoma patients possess a druggable hotspot V600E/K mutation in the BRAF protein kinase. FDA-approved combination therapies of BRAF and MEK inhibitors are available that provide survival benefits...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-018-0171-x

    authors: Dankner M,Rose AAN,Rajkumar S,Siegel PM,Watson IR

    更新日期:2018-06-01 00:00:00

  • WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t(1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma.

    abstract::Neuroblastoma (Nb) is a malignancy of the sympathetic nervous system which affects children in their first decade. It is the most common extra-cranial solid tumor in children with an incidence of approximately 1 in 8-10 000 live births annually and accounts for approximately 10% of all children's cancers. Ganglioneuro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205734

    authors: Sossey-Alaoui K,Su G,Malaj E,Roe B,Cowell JK

    更新日期:2002-08-29 00:00:00

  • Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity.

    abstract::Grb2 is an adaptor protein that links receptor and cytoplasmic tyrosine kinases to the Ras signalling pathway by binding the Ras-specific guanine nucleotide exchange factor, Sos1, through its SH3 domains. The Grb2-SH3 domain binding has been localized to the carboxy-terminal two hundred amino acids of Sos1 (Sos1-c). B...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sastry L,Lin W,Wong WT,Di Fiore PP,Scoppa CA,King CR

    更新日期:1995-09-21 00:00:00

  • A comprehensive profile of recurrent glioblastoma.

    abstract::In spite of relentless efforts to devise new treatment strategies, primary glioblastomas invariably recur as aggressive, therapy-resistant relapses and patients rapidly succumb to these tumors. Many therapeutic agents are first tested in clinical trials involving recurrent glioblastomas. Remarkably, however, fundament...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.85

    authors: Campos B,Olsen LR,Urup T,Poulsen HS

    更新日期:2016-11-10 00:00:00

  • Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells.

    abstract::The IGF2 gene, which encodes a growth factor, is subject to genomic imprinting. The frequently observed loss of IGF2 imprinting in a variety of tumors has been suggested to contribute to neoplasia. Since these reports have not documented the imprinting status of IGF2 at the cellular level, it cannot be excluded that t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201501

    authors: He L,Cui H,Walsh C,Mattsson R,Lin W,Anneren G,Pfeifer-Ohlsson S,Ohlsson R

    更新日期:1998-01-08 00:00:00

  • Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.

    abstract::Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205133

    authors: Koch CA,Huang SC,Zhuang Z,Stolle C,Azumi N,Chrousos GP,Vortmeyer AO,Pacak K

    更新日期:2002-01-17 00:00:00

  • Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.

    abstract::The c-erbB-2 proto-oncogene encodes a receptor tyrosine kinase (RTK) closely related to the epidermal growth factor receptor (EGFR). Overexpression of erbB-2 occurs in approximately 20% of human breast tumours, where increased expression correlates with poor patient prognosis. The EGFR is coupled to the Ras signalling...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Janes PW,Daly RJ,deFazio A,Sutherland RL

    更新日期:1994-12-01 00:00:00

  • Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.

    abstract::The naevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by multiple developmental defects and cancer susceptibility, in particular to basal cell carcinomas (BCCs). Medulloblastomas, primitive neuroectodermal tumours (PNETs) arising in childhood, occur in about 3-5% of NBCCS pa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201340

    authors: Vorechovský I,Tingby O,Hartman M,Strömberg B,Nister M,Collins VP,Toftgård R

    更新日期:1997-07-17 00:00:00

  • Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.

    abstract::The mechanisms by which the p53 tumour suppressor protein would, in vivo, co-ordinate the adaptive response to genotoxic stress is poorly understood. p53 has been shown to transactivate several genes that could be involved in two main cellular responses, growth arrest and apoptosis. To get further insight into the tis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203366

    authors: Bouvard V,Zaitchouk T,Vacher M,Duthu A,Canivet M,Choisy-Rossi C,Nieruchalski M,May E

    更新日期:2000-02-03 00:00:00

  • Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.

    abstract::We screened cdc2 kinase inhibitors from cultured mediums of micro organisms using purified mouse cyclin B-cdc2 kinase and a specific substrate peptide for cdc2 kinase. A selective inhibitor of cdc2 kinase was isolated from the cultured medium of Aspergillus species F-25799, and identified as butyrolactone I. Butyrolac...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kitagawa M,Okabe T,Ogino H,Matsumoto H,Suzuki-Takahashi I,Kokubo T,Higashi H,Saitoh S,Taya Y,Yasuda H

    更新日期:1993-09-01 00:00:00

  • E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.

    abstract::The E2F1 transcription factor, which is deregulated in most human cancers by mutations in the p16-cyclin D-Rb pathway, has both oncogenic and tumor-suppressive properties. This is dramatically illustrated by the phenotype of an E2F1 transgenic mouse model that spontaneously develops tumors in the skin and other epithe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209120

    authors: Russell JL,Weaks RL,Berton TR,Johnson DG

    更新日期:2006-02-09 00:00:00

  • The 'WS motif' common to v-mpl and members of the cytokine receptor superfamily is dispensable for myeloproliferative leukemia virus pathogenicity.

    abstract::Several motifs are conserved in the extracellular domain of the cloned chains of the recently described cytokine receptor superfamily. One of them, usually close to the transmembrane region, is the 'WS motif'. Its function remains unknown, but it has been recently shown that the integrity of this motif is essential fo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Bénit L,Charon M,Cocault L,Wendling F,Gisselbrecht S

    更新日期:1993-03-01 00:00:00

  • Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.

    abstract::The discovery of constitutive nuclear factor-κB (NF-κB) activation in Hodgkin's lymphoma tumor cells almost two decades ago was one of the first reports that directly connected deregulated NF-κB signaling to human cancer. Subsequent studies demonstrated that enhanced NF-κB signaling is a common hallmark of many lympho...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.565

    authors: Nagel D,Vincendeau M,Eitelhuber AC,Krappmann D

    更新日期:2014-12-11 00:00:00

  • Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.

    abstract::The LoVo colon carcinoma cell line that presents two wild type p53 alleles was used as the recipient for a series of transfections with p53 expression vectors coding for wild-type or three different mutants (143ala, 175his or 273his). The parental cell line as well as all clones that had rearranged the plasmid with co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Pocard M,Chevillard S,Villaudy J,Poupon MF,Dutrillaux B,Remvikos Y

    更新日期:1996-02-15 00:00:00

  • Apoptosis and melanoma chemoresistance.

    abstract::Melanoma is the most aggressive form of skin cancer and is notoriously resistant to all current modalities of cancer therapy. A large set of genetic, functional and biochemical studies suggest that melanoma cells become 'bullet proof' against a variety of chemotherapeutic drugs by exploiting their intrinsic resistance...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206454

    authors: Soengas MS,Lowe SW

    更新日期:2003-05-19 00:00:00

  • Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.

    abstract::The HER-2/neu proto-oncogene is frequently amplified or overexpressed in many different types of human cancers, a phenomenon that has been shown to correlate with shorter survival time and lower survival rate in ovarian cancer patients. We previously reported that increased HER-2/neu expression led to more severe mali...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yu D,Matin A,Xia W,Sorgi F,Huang L,Hung MC

    更新日期:1995-10-05 00:00:00

  • Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression.

    abstract::Bone morphogenetic proteins (BMPs) are known to play an important role in melanoma development and progression. However, the downstream targets of BMPs have not been investigated thus far. Therefore, we treated melanoma cell lines with the Smad-specific BMP inhibitor Dorsomorphin and performed a cDNA microarray. We id...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.115

    authors: Braig S,Bosserhoff AK

    更新日期:2013-02-14 00:00:00

  • High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF.

    abstract::We recently reported the cloning and overexpression of full-length forms of human fibroblast growth factor (FGF) receptors, bek and flg. These receptors contain three immunoglobulin (Ig)-like domains and an unusual acidic motif in the extracellular region, a single transmembrane segment and a protein tyrosine kinase c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Crumley G,Bellot F,Kaplow JM,Schlessinger J,Jaye M,Dionne CA

    更新日期:1991-12-01 00:00:00

  • OTX1 expression in breast cancer is regulated by p53.

    abstract::The p53 transcription factor has a critical role in cell stress response and in tumor suppression. Wild-type p53 protein is a growth modulator and its inactivation is a critical event in malignant transformation. It has been recently demonstrated that wild-type p53 has developmental and differentiation functions. Inde...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.31

    authors: Terrinoni A,Pagani IS,Zucchi I,Chiaravalli AM,Serra V,Rovera F,Sirchia S,Dionigi G,Miozzo M,Frattini A,Ferrari A,Capella C,Pasquali F,Curto FL,Albertini A,Melino G,Porta G

    更新日期:2011-07-07 00:00:00